Oleander Phytochemical Composition for Viral Infection Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for viral infections, particularly those caused by Arenaviridae, Bunyaviridae, Filoviridae, Flaviviridae, and Coronaviridae families, lack effective pharmaceutical compositions and methods, with existing antiviral agents showing unpredictable efficacy and potential toxicity.

Innovation Solution

Development of a pharmaceutical composition containing oleandrin, oleanolic acid, and betulinic acid, administered chronically to prevent or treat viral infections by inhibiting viral replication and reducing infectivity, specifically targeting alpha-3 to alpha-1 isoforms of Na,K-ATPase in virally infected cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing antiviral agents are used to treat viral infections, then viral replication can be inhibited, but the efficacy is unpredictable and potential toxicity occurs

Engineering Contradiction:
Improveefficacy predictabilityVSAvoidtoxicity
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent uses a composite extract containing multiple compounds from Nerium oleander (cardiac glycosides, triterpenes, flavonoids, and other phytochemicals) working synergistically to treat viral infections. This multi-component composition provides reliable and predictable antiviral efficacy while the natural balance of components reduces toxicity compared to single-agent therapies.

Inventive Principle:
Principle #40Composite materials

2Productivity

If conventional extraction methods (boiling water, organic solvents) are used to prepare antiviral compositions, then extraction efficiency can be achieved, but the process is complex and may leave residual solvents

Engineering Contradiction:
Improveextraction efficiencyVSAvoidextraction process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent employs supercritical fluid extraction, which changes the physical parameters (temperature and pressure) of the extraction medium to achieve optimal extraction efficiency. The supercritical state allows for high penetration and solubility, and upon depressurization, the solvent returns to gaseous state, eliminating complex separation steps and residual solvent concerns.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces traditional thermal extraction methods (boiling water) and chemical solvent extraction with supercritical fluid extraction, substituting mechanical/thermal processes with a phase-based extraction system that is more efficient and environmentally friendly.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If high doses of antiviral agents are administered to ensure efficacy, then viral replication is better inhibited, but toxicity increases

Engineering Contradiction:
Improveantiviral efficacyVSAvoidtoxicity
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The multi-component phytochemical composition from Nerium oleander provides synergistic antiviral activity, where multiple compounds work together to enhance efficacy at lower doses. This reduces the need for high single-agent dosing and consequently lowers toxicity.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS11806359B2Method and compositions for treating Coronavirus infection
Publication Date: 2023.11.07 AVILA HERBALS LLC
  • US11806359B2 patent drawing
  • US11806359B2 patent drawing
  • US11806359B2 patent drawing

AI summary

A method of treating viral infection, such as viral infection caused by a virus of the Coronaviridae family, is provided. A composition having at least oleandrin or digoxin is used to treat the viral infection or the disease state of said viral infection.